This is a community-generated profile. If you work at Replimune Group, to claim it.
DiscoverStartupsReplimune GroupReplimune Group Funding Rounds, Valuation & Investors
Replimune Group company logo
Replimune Group develops next-generation oncolytic immunotherapies for cancer treatment201-500 Employees
  • Recently funded
    Raised funding in the past six months

Replimune Group Funding

$150M
11 round
Replimune Group has secured funding across 1 rounds, totaling in an amount of $150M. Their most recent funding was raised on August 10, 2026.

Funding Rounds

S
$150000000